Manufacture Safe and Effective Medical Devices
The U.S. Food and Drug Administration’s (FDA) 21 CFR Part 820 Quality System Regulation (QSR) details the requirements governing the manufacture of safe and effective medical devices. Our new guide is an easy-to-understand overview of the regulation and your responsibilities for achieving compliance. You will learn:
With MasterControl quality management system (QMS) and manufacturing execution system (MES) software, you never have to sacrifice compliance to achieve efficiency. Our solutions are designed to ensure compliance with regulatory requirements, while also increasing operational efficiency. By natively connecting quality and manufacturing data in one powerful digital tool, MasterControl enhances data connectivity and provides real-time visibility into processes across the entire life cycle of your regulated products. Read on to learn how to add efficiencies, embed quality into manufacturing operations, and bring your life-changing products to market faster.
The QMS components of the 21 CFR Part 820 quality system regulation include the organisational structure, responsibilities, processes, and resources for implementing quality management in medtech manufacturing.
Manufacturers must apply risk management measures to product development, design, manufacturing, and postmarket surveillance; make decisions to accept or mitigate risks; and keep records of all risk management activities.
Companies found to be noncompliant with FDA 21 CFR Part 820 could receive a warning letter from the regulatory agency, experience a product recall, or have the organisation completely shut down.
Deploying regulatory compliance software is the best way to prepare for inspections and comply with FDA 21 CFR Part 820. Automating and integrating all quality tasks ensures quality throughout the product life cycle.
The 21 CFR Part 820 QSR contains detailed regulations manufacturers must comply with. The following are key components of the regulation.
Risk management is pivotal to 21 CFR Part 820 compliance. It must be applied throughout product development, design change, manufacturing, and postmarket surveillance.
Manufacturers are required to establish and maintain procedures for creating, controlling, updating, and archiving documents.
Manufacturers must identify, investigate, and prevent the recurrence of product and quality problems. This demonstrates that their quality system is effective.
Manufacturers must ensure that all equipment meets specified requirements, including being appropriately designed and receives the required maintenance, calibration, and cleaning.
Gain valuable insight about FDA 21 CFR Part 820 in one helpful overview.
Get Your 21 CFR Part 820 Compliance SummaryConsistently Achieve 21 CFR Part 820 compliance
Eliminate labour-intensive quality management tasks with a collaborative workspace, automated document control, and integrated enterprise management systems.
Input data directly into tablets or computers. Digital records don’t accept out-of-specification (OOS) or omitted entries, so all records are error-free.
All stakeholders have visibility into all CAPA processes all the time. Connecting appropriate personnel with system data empowers them to make improvements on the spot.
Employ a digitally connected, data-driven approach to identifying and mitigating risks before they result in costly delays, rework, or product recalls.
Regulatory compliance software manages your maintenance schedule and automatically triggers maintenance tasks before they are due.
Find more information about how a modern digital software solution makes compliance with FDA 21 CFR Part 820.
Our digital tools embed efficiency and continuity into your organisation’s culture, helping you comply with all of the FDA 21 CFR Part 820 requirements.
Contact one of our experts today to see how advanced digital solutions can ease your compliance burdens.